NCT04765371View on ClinicalTrials.gov

Comparison Between Prednisolone and Dexamethasone on Mortality in Patients on Oxygen Therapy, with CoViD-19

PHASE3CompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

March 3, 2021

Primary Completion Date

February 10, 2022

Study Completion Date

February 10, 2022

Conditions
Coronavirus Infection
Interventions
DRUG

DEXAMETHASONE

Patients will take 60 mg per day of Prednisolone (40 mg morning and 20 md evening) between D1 to D10

DRUG

PREDNISOLONE

Patients will take 60 mg per day of Prednisolone (40 mg morning and 20 md evening) between D1 to D10

Trial Locations (8)

43012

Department of Internal Medicine, Hospital Emile Roux - Le Puy-en-Velay, Le Puy-en-Velay

93200

Department of Infectious and respiratory Diseases, Hospital Delafontaine, Saint-Denis

95100

Department of Emergency, Hospital Victor Dupouy, Argenteuil

95300

Department of Infectious and Tropical Diseases, Hospital René Dubos,, Pontoise

95500

Department of Infectious Medicine, Hospital of Gonesse, Gonesse

95600

Department of Infectious and Tropical Diseases, Hospital Simone Veil, Eaubonne

Unknown

Department of Pneumology and Infectious Medicine, Hospital Carnelle Portes de l'Oise, Beaumont

02321

Department of Pneumology and Infectious Diseases, Hospital of Saint-Quentin, Saint-Quentin

All Listed Sponsors
lead

Hôpital NOVO

OTHER

NCT04765371 - Comparison Between Prednisolone and Dexamethasone on Mortality in Patients on Oxygen Therapy, with CoViD-19 | Biotech Hunter | Biotech Hunter